Mirae Asset Global Investments Co., Ltd. Argenx Se Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Argenx Se stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,283 shares of ARGX stock, worth $1.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,283
Previous 3,285
0.06%
Holding current value
$1.89 Million
Previous $2.02 Million
3.81%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ARGX
# of Institutions
498Shares Held
28.5MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.1 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.61 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.23 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.12 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$712 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...